Tag: embryonic stem cells

Baby Monkeys Have Cells From Up to Six Parents

By Veronique Greenwood | January 9, 2012 4:31 pm

Roku and Hex from OHSU News on Vimeo.

Researchers have announced the birth of three unusual, though healthy, baby monkeys. They are the first non-mouse chimeras—creatures made up of cells from multiple other parents—to be created by science.

Making chimeric mice is a time-consuming but fairly routine part of biology these days: embryos are injected with modified cultured stem cells containing the traits the researchers desire (like glowing in the dark). Those embryos grow up into mice who have some glow-in-the-dark cells and some normal cells, called chimeras. These chimeras are useful because if any of them have glow-in-the-dark sperm or eggs, they can be bred with each other to produce babies who are 100% glow-in-the-dark.

Read More

CATEGORIZED UNDER: Health & Medicine

Helpful Mouse Fetuses Naturally Send Stem Cells to Mom to Fix Her Damaged Heart

By Valerie Ross | November 21, 2011 2:23 pm

Cardiomyocytes damaged by a heart attack

What’s the News: Scientists are devoting countless research hours to treatments based on embryonic stem cells, differentiating these blank-slate cells from embryos into brain cells, light-sensing retinal cells, blood cells, and more to replace damaged or destroyed tissues in the body. Now, a new study in mice shows such that nature has arrived at just such a solution, too: When a pregnant mouse has a heart attack, her fetus donates some of its stem cells to help rebuild the damaged heart tissue.

Read More

CATEGORIZED UNDER: Health & Medicine, Top Posts

New Neurons From Stem Cells Get Us Closer to Treating Parkinson's

By Valerie Ross | November 8, 2011 4:46 pm

Neurons damaged by Parkinson’s disease

What’s the News: Scientists have reversed Parkinson’s disease-like brain damage and motor problems in mice and rats using neurons grown from human embryonic stem cells. The new technique, described online in Nature earlier this week, brings scientists closer to similar treatments for people with Parkinson’s.

Read More

CATEGORIZED UNDER: Health & Medicine, Mind & Brain

E.S. Sees: Biologists Grow Entire Retina From Mouse Embryonic Stem Cells

By Veronique Greenwood | April 8, 2011 2:37 pm

cell sac forms

The stem cells formed a sac that then folded in half
a couple days later (see image above, courtesy of Nature),
forming the optic cup.

What’s the News: Give a blob of cells the right environment—lots of nutrients, special chemical signals, and a comfy gel cushion—and they just might grow you a body part. In a feat of bioengineering, scientists at the RIKEN Center for Developmental Biology in Japan have grown a retina from mouse embryonic stem cells. Remarkably, much of the development happened spontaneously, indicating that even undifferentiated cells have a blueprint in mind. Researchers hope the work will someday yield transplantable retinas for people with diseases like retinitis pigmentosa.

“When I received the manuscript, I was stunned, I really was,” commented human molecular geneticist Robin Ali (via Nature News). “I never though I’d see the day where you have recapitulation of development in a dish.”

Read More

CATEGORIZED UNDER: Health & Medicine, Living World

Bringing Embryonic Stem Cells to the Blind: Clinical Test Gets FDA Approval

By Jennifer Welsh | January 3, 2011 6:14 pm

Embryonic stem cell treatments are edging closer to mainstream medicine. An experimental treatment just approved for clinical trials may provide hope to the 10 to 15 million elderly patients in the United States who suffer from a common form of macular degeneration, which causes gradual blindness.

The biotech company behind the treatment, Advanced Cell Technology, Inc., previously won FDA approval to try an embryonic stem cell treatment on patients with a rare, juvenile form of macular degeneration. The new FDA-approved trial will use similar techniques, but targets a much broader patient base.

“ACT is now the first company to receive FDA clearance for two hESC (human embryonic stem cell) trials, and is now a true translational leader in the field of regenerative medicine,” said chief executive Gary Rabin. “It marks a major step forward, not just within the stem cell sector, but, potentially for modern healthcare techniques.” [AFP]

Read More

CATEGORIZED UNDER: Health & Medicine

FDA Green-Lights an Embryonic Stem Cell Treatment for Vision Loss

By Eliza Strickland | November 22, 2010 3:32 pm

Stargardt-RetinaEmbryonic stem cell treatments are finally breaking out of the lab and arriving in the clinic. In October, the first federally approved trial of a treatment derived from these controversial cells got underway in patients with spinal cord injuries. Now, the FDA has approved a second trial, this one to test a treatment for a rare disease that causes serious vision loss or blindness.

The company behind the trial, Advanced Cell Technology, will test the safety and efficacy of the treatment on 12 patients.

The trial will examine the safety of a therapy for Stargardt’s Macular Degeneration, an inherited juvenile eye disease affecting an estimated 1 in 10,000 young people in the US. As the disease progresses, a layer of the retina called the retinal pigment epithelium (RPE) degenerates, causing vision loss. It’s hoped the new therapy would also work for other types of macular degeneration, a widespread cause of blindness, particularly in the elderly. [Nature blog]

Read More

CATEGORIZED UNDER: Health & Medicine, Mind & Brain

First Patient Is Injected With Embryonic Stem Cell Treatment

By Eliza Strickland | October 12, 2010 11:33 am

embryonic-stem-cellsYes, it’s a milestone. The first federally approved trial of an embryonic stem cell therapy has begun, and the first patient with a spinal cord injury has been injected with a treatment made from embryonic stem cells. But if all goes well with the trial, conducted by the biotech company Geron, there won’t be any dramatic results–the trial is simply intended to test the treatment’s safety, and patients will receive very low doses of the stem cell concoction.

The patient, whose name was not disclosed, is enrolled at the Shepherd Center, a rehabilitation center in Atlanta; the company has said it plans to enroll 8 to 10 patients in the study at sites around the country. Even if all goes well in the early-stage study, the treatment faces many years of testing for effectiveness before it could be approved as a therapy for spinal injuries. [New York Times]

For the trial, which gained final approval in August, Geron is working with a technique pioneered by the neurobiologist Hans Keirstead, who licensed the technology to Geron.

Read More

CATEGORIZED UNDER: Health & Medicine

Federal Judge Won't Delay His Ban on Embryonic Stem Cell Research

By Andrew Moseman | September 8, 2010 12:28 pm

StemCellsUPDATE: In a terse statement (pdf) released today—Thursday, Sept. 9—the U.S. Court of Appeals has issued a stay on the ruling of District Court judge Royce Lamberth against federal funding for embryonic stem cell research. Earlier in the week, Lamberth refused to grant a stay on his own ruling; see below. This doesn’t mean the appeals court is siding with the Justice Department against Lamberth’s ruling; it simply means the three judges want adequate time to consider the ruling and its repercussions. And because the stay lasts until September 20 at least, the National Institutes of Health can re-up the $54 million in projects currently due for annual renewal.


The ruling stands, for now.

The Obama Administration asked U.S. District Court judge Royce Lamberth to grant a stay of his injunction against federal funding for embryonic stem cell research, insisting that it could trigger job losses and research setbacks. But yesterday the judge issued an order in which he refused to lift the ban, and dismissed the Justice Department’s arguments that the ruling would cause chaos by immediately shutting down all research.

Lamberth indicated that his injunction was less restrictive than had been interpreted by the Obama administration. “Defendants are incorrect about much of their ‘parade of horribles’ that will supposedly result from this Court’s preliminary injunction,” Lamberth wrote. The ruling did not necessarily apply to research that had been funded under guidelines issued during the Bush administration or that had previously been “awarded and funded,” Lamberth wrote. [Washington Post]

Read More

CATEGORIZED UNDER: Health & Medicine

Feds Challenge Judge's Injunction Against Stem Cell Research

By Andrew Moseman | September 1, 2010 4:40 pm

StemCellsThe U.S. Department of Justice has now officially asked Royce Lamberth, the District Court judge who ruled that the Obama administration’s expansion of embryonic stem cell research violated federal law, to suspend the injunction he issued last week that prevents any more funds from going to stem cell projects. The DOJ is also taking the case to the Court of Appeals.

In a 23-page legal filing, Justice Department lawyers said the stay was needed to avoid terminating research projects midstream and negating years of scientific progress toward finding new treatments for devastating illnesses. The department said the ruling would cause irrevocable harm to “millions of extremely sick or injured people” who could benefit from stem-cell research, as well to scientists and taxpayers “who have already spent hundreds of millions of dollars on such research through public funding of projects which will now be forced to shut down and, in many cases, scrapped altogether.” [Wall Street Journal]

Most ongoing projects had been allowed to continue for now, but only if they used National Institutes of Health money to research at their home universities. However, NIH head Francis Collins notes (pdf) the $54 million in projects due for renewal at the end of this month—without a change in the ruling, NIH is forbidden to renew them. Additionally, projects underway on the NIH campus itself have been ordered shut down.

DISCOVER will keep you posted on further updates.

Related Content:
80beats: Stem Cell Decision Fallout: What’s Next, and Who Were the Plaintiffs?
80beats: Judge: Obama’s Expansion of Stem Cell Research Violates Federal Law
80beats: The Trouble With Lab-Created Stem Cells—and Why They Won’t Displace Embryonic Ones
80beats: FDA Green-Lights First Trials Using Embryonic Stem Cells (Again)

Image: iStockphoto

CATEGORIZED UNDER: Health & Medicine

Stem Cell Decision Fallout: What's Next, and Who Were the Plaintiffs?

By Andrew Moseman | August 25, 2010 5:42 pm

test tubes220Stem cell work will go on. But the shape of its long-term future is a mystery.

A court ruling yesterday that said the federal government can’t fund embryonic stem cell research even if no money goes to destroying embryos has thrown the field into confusion. Today, though, NIH head Francis Collins says that while the government can’t fund new projects (at least until the legal dispute is resolved), researchers in the middle of federally funded projects can continue.

The Justice Department said yesterday it will appeal the injunction issued Monday by a federal judge in Washington. Collins said that if the decision stands, it puts in jeopardy a fast-moving area of science that offers potential treatments for spinal cord injury, diabetes, and Parkinson’s disease, as well as help in screening new drugs. “This decision has just poured sand into this engine of discovery,’’ he said [Boston Globe].

Read More

CATEGORIZED UNDER: Health & Medicine

Discover's Newsletter

Sign up to get the latest science news delivered weekly right to your inbox!


80beats is DISCOVER's news aggregator, weaving together the choicest tidbits from the best articles covering the day's most compelling topics.

See More

Collapse bottom bar